Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.

Investor	Date	% Owned	Market Value	Shares	Chg. Shares	Chg. Shares %	% Portfolio
The Vanguard Group, Inc.	2024-09-30	11.14681%	$1.23B	20.2M	-158.3K	-0.8%	0.0%
BlackRock, Inc.	2024-09-30	8.76471%	$963.61M	15.9M	554.6K	3.6%	0.0%
State Street Global Advisors, Inc.	2024-09-30	4.10505%	$451.32M	7.5M	113.1K	1.5%	0.0%
Capital Research and Management Company	2024-09-30	3.52511%	$387.56M	6.4M	1.5M	30.3%	0.0%
Vanguard Index Funds - Vanguard Total Stock Market ETF	2024-10-31	2.98719%	$328.42M	5.4M	-20.4K	-0.4%	0.0%
Vanguard Index Funds - Vanguard S&P 500 ETF
Norges Bank Investment Management
Government Pension Fund Global
Millennium Management LLC
Vanguard Index Funds - Vanguard Small-Cap ETF
Geode Capital Management, LLC
Elliott Management Corporation
Barclays PLC Private Banking & Investment Banking Investment
Balyasny Asset Management L.P.
Fidelity International Ltd
Capital World Growth and Income Fund
Bank of America Corporation, Asset Management Arm
Invesco Capital Management LLC
UBS Asset Management AG
Vanguard Index Funds - Vanguard Small-Cap Growth ETF

Catalent, Inc.

Top Holders